有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 3-[4-Amino-3-[(4-methylphenyl)methylsulfanyl]-5-oxo-1,2,4-triazin-6-yl]propanoate | —— | C14H15N4O3S- |
|
—— | (2R)-1-ethoxy-3-pyrimidin-2-ylsulfanylpropan-2-ol | —— | C9H14N2O2S |
|
—— | (2S)-1-ethoxy-3-pyrimidin-2-ylsulfanylpropan-2-ol | —— | C9H14N2O2S |
|
—— | N-[(2S)-2-(4-methylpiperidin-1-yl)-2-thiophen-2-ylethyl]-2-phenylsulfanylacetamide | —— | C20H26N2OS2 |
|
—— | N-[(2R)-2-(4-methylpiperidin-1-yl)-2-thiophen-2-ylethyl]-2-phenylsulfanylacetamide | —— | C20H26N2OS2 |
|
—— | (2S)-2-(4-chlorophenyl)sulfanyl-N-(2-methyl-2-piperidin-1-ylpropyl)propanamide | —— | C18H27ClN2OS |
|
—— | (2R)-1-(azepan-1-yl)-2-(1-oxidopyridin-1-ium-2-yl)sulfanylpropan-1-one | —— | C14H20N2O2S |
|
—— | (2R)-2-(4-chlorophenyl)sulfanyl-N-(2-methyl-2-piperidin-1-ylpropyl)propanamide | —— | C18H27ClN2OS |
|
—— | (2S)-N-(2-bromoprop-2-enyl)-2-propan-2-ylsulfonylpropanamide | —— | C9H16BrNO3S |
|
—— | N-cyclopentyl-2-[4-(3,4-difluorophenyl)-3-oxopyrazin-2-yl]sulfanylacetamide | —— | C17H17F2N3O2S |
|
—— | 2-[4-(3,4-difluorophenyl)-3-oxopyrazin-2-yl]sulfanyl-N-[(4-methylphenyl)methyl]acetamide | —— | C20H17F2N3O2S |
|
—— | 2-[4-(3-fluoro-4-methylphenyl)-3-oxopyrazin-2-yl]sulfanyl-N-[(4-methylphenyl)methyl]acetamide | —— | C21H20FN3O2S |
|
—— | 2-[4-(4-Bromo-3-methylphenyl)-3-oxopyrazin-2-yl]sulfanylacetamide | —— | C13H12BrN3O2S |
|
—— | 2-[4-(3-chloro-4-methylphenyl)-3-oxopyrazin-2-yl]sulfanyl-N-cyclopentylacetamide | —— | C18H20ClN3O2S |
|
—— | 2-((4-(3-chloro-4-methylphenyl)-3-oxo-3,4-dihydropyrazin-2-yl)thio)-N-phenethylacetamide | —— | C21H20ClN3O2S |
|
—— | 2-((4-(3,4-difluorophenyl)-3-oxo-3,4-dihydropyrazin-2-yl)thio)-N-phenethylacetamide | —— | C20H17F2N3O2S |
|
—— | (2R)-N-(2-bromoprop-2-enyl)-2-propan-2-ylsulfonylpropanamide | —— | C9H16BrNO3S |
|
—— | 2-[4-(3-chloro-4-methylphenyl)-3-oxopyrazin-2-yl]sulfanyl-N-[(4-methylphenyl)methyl]acetamide | —— | C21H20ClN3O2S |
|
—— | 1-(3,4-Difluorophenyl)-3-{[(3-fluorophenyl)methyl]sulfanyl}-1,2-dihydropyrazin-2-one | —— | C17H11F3N2OS |
|
—— | N-cyclohexyl-2-[4-(3,4-difluorophenyl)-3-oxopyrazin-2-yl]sulfanylacetamide | —— | C18H19F2N3O2S |
|
—— | (2S)-1-(azepan-1-yl)-2-(1-oxidopyridin-1-ium-2-yl)sulfanylpropan-1-one | —— | C14H20N2O2S |
|
—— | 2-[4-(3-chloro-4-fluorophenyl)-3-oxopyrazin-2-yl]sulfanyl-N-cyclohexylacetamide | —— | C18H19ClFN3O2S |
|
—— | N-cyclohexyl-2-[4-(3-fluoro-4-methylphenyl)-3-oxopyrazin-2-yl]sulfanylacetamide | —— | C19H22FN3O2S |
|
—— | N-[(1S)-1-cyanoethyl]-2-(4-fluorophenyl)sulfanylacetamide | —— | C11H11FN2OS |
|
—— | N-[(1R)-1-cyanoethyl]-2-(4-fluorophenyl)sulfanylacetamide | —— | C11H11FN2OS |
|
—— | 2-[4-(3-Chloro-4-fluorophenyl)-3-oxopyrazin-2-yl]sulfanylacetamide | —— | C12H9ClFN3O2S |
|
—— | 2-[4-(3-chloro-4-methylphenyl)-3-oxopyrazin-2-yl]sulfanyl-N-cyclohexylacetamide | —— | C19H22ClN3O2S |
|
—— | N-benzyl-2-[4-(3-fluoro-4-methylphenyl)-3-oxopyrazin-2-yl]sulfanylacetamide | —— | C20H18FN3O2S |
|
—— | N-[(1R)-1-cyanoethyl]-3-phenylsulfanylpropanamide | —— | C12H14N2OS |
|
—— | N-[(1S)-1-cyanoethyl]-2-(4-methylphenyl)sulfanylacetamide | —— | C12H14N2OS |
|
—— | N-[(1S)-1-cyanoethyl]-3-(4,6-dimethyl-2-methylsulfanylpyrimidin-5-yl)propanamide | —— | C13H18N4OS |
|
—— | N-[(1S)-1-cyanoethyl]-3-phenylsulfanylpropanamide | —— | C12H14N2OS |
|
—— | N-[(1R)-1-cyanoethyl]-3-(4,6-dimethyl-2-methylsulfanylpyrimidin-5-yl)propanamide | —— | C13H18N4OS |
|
—— | N-[(1R)-1-cyanoethyl]-2-(2-fluorophenyl)sulfanyl-5-nitrobenzamide | —— | C16H12FN3O3S |
|
—— | 3-(4-chlorophenyl)sulfanyl-N-(3-morpholin-4-ium-4-ylpropyl)propanamide | —— | C16H24ClN2O2S+ |
|
—— | N-[(4-fluorophenyl)methyl]-N-methyl-2-[[5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C21H22FN3O2S |
|
—— | N-[(1S)-1-cyanoethyl]-2-(2-fluorophenyl)sulfanyl-5-nitrobenzamide | —— | C16H12FN3O3S |
|
—— | (2S)-2-(2,5-dimethylphenyl)sulfanyl-N-[(1S)-1-phenylethyl]propanamide | —— | C19H23NOS |
|
—— | N-(furan-2-ylmethyl)-N-methyl-2-[[5-[(2R)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C19H21N3O3S |
|
—— | N-[(2R)-1-methoxypropan-2-yl]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C9H15N3O2S2 |
|
—— | (2R)-2-(4-chlorophenyl)sulfanyl-N-(2-methyl-2-morpholin-4-ylpropyl)propanamide | —— | C17H25ClN2O2S |
|
—— | N-[(1S)-1-(4-chlorophenyl)ethyl]-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]acetamide | —— | C14H15ClN2OS2 |
|
—— | (2S)-2-(2,4-dimethylphenyl)sulfanyl-N-[(1S)-1-phenylethyl]propanamide | —— | C19H23NOS |
|
—— | N-(furan-2-ylmethyl)-N-methyl-2-[[5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C19H21N3O3S |
|
—— | 2-(2-chlorophenyl)-5-[[5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-1,3,4-oxadiazole | —— | C20H17ClN4O2S |
|
—— | (2S)-2-(4-chlorophenyl)sulfanyl-N-(2-methyl-2-morpholin-4-ylpropyl)propanamide | —— | C17H25ClN2O2S |
|
—— | N-[(1R)-1-(4-chlorophenyl)ethyl]-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]acetamide | —— | C14H15ClN2OS2 |
|
—— | N-[(2S)-1-methoxypropan-2-yl]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C9H15N3O2S2 |
|
—— | N-[(4-fluorophenyl)methyl]-N-methyl-2-[[5-[(2R)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C21H22FN3O2S |
|
—— | N-[(2S)-2-(dimethylamino)-2-phenylethyl]-2-(1,3,4-thiadiazol-2-ylsulfanyl)acetamide | —— | C14H18N4OS2 |
|